Prevention of Postoperative Ventral Hernias

February 11, 2022 updated by: Ryazan State Medical University

Prevention of Postoperative Ventral Hernias After Median Laparotomy in Urgent Surgery

The research is aimed at identifying factors of herniation after median laparotomy and developing surgical methods for preventing postoperative ventral hernias and eventrations.

Study Overview

Detailed Description

At the first stage, an analysis of the prevalence of postoperative ventral hernias in patients after median laparotomies in urgent surgery will be performed, with the identification of factors contributing to the development of postoperative ventral hernias. At the next stage, the investigators will search for the most reliable methods of suturing the white line of the abdomen, taking into account the risk of hernia formation, with their implementation in patients operated in an emergency through median laparotomic access in comparison with traditionally used methods. In conclusion, an algorithm will be developed for selecting the method of surgical prevention of postoperative ventral hernias, taking into account the risk of their development.

Study Type

Observational

Enrollment (Actual)

700

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ryazan, Russian Federation
        • RyazSMU
    • Ryazan Region
      • Ryazan, Ryazan Region, Russian Federation, 390026
        • RyazSMU

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The prospective study included 700 patients, including those operated through a midline laparotomic approach to identify factors of herniation, and those who are planned to have a midline laparotomy in order to choose a rational method of suturing a laparotomic wound, taking into account the risk of incisional hernia formation. Taking into account the degree of risk of postoperative ventral hernia development and the choice of the method of its prevention, the patients were divided into 4 groups.

Description

Inclusion Criteria:

  1. Patients of both sexes aged 18 years and older who are expected to perform median laparotomy on a planned or emergency basis.
  2. Patients who have signed an informed consent to participate in the study, after the purpose and meaning of the study have been explained to them.
  3. Patients who follow the doctor's instructions.

Exclusion Criteria:

  1. The death of the patient.
  2. Stage IV cancer
  3. Hernia repair with hernioplasty, including simultaneous surgery
  4. Refusal of the patient to cooperate with the researcher.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Low risk of herniation.
Use of any method of suturing, including modified.
Suturing the white line of the abdomen with the help of developed techniques aimed at preventing hernias and eventrations
The average risk of hernia formation
The application of modified methods of closure of laparotomy wound.
Suturing the white line of the abdomen with the help of developed techniques aimed at preventing hernias and eventrations
high risk of herniation
The use of alloplastic methods of closure of laparotomy wound.
Suturing the white line of the abdomen with the help of developed techniques aimed at preventing hernias and eventrations
The presence of eventrations
The use of alloplastic methods of suturing a laparotomic wound in the absence of suppuration.
Suturing the white line of the abdomen with the help of developed techniques aimed at preventing hernias and eventrations

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wound complications
Time Frame: 2 weeks
Frequency of wound complications in the early postoperative period.
2 weeks
Eventration
Time Frame: 2 weeks
Frequency of events in the early postoperative period
2 weeks
Pain syndrome
Time Frame: 2 year
The severity of pain syndrome in the postoperative scar after midline laparotomy using a verbal scale of pain syndrome
2 year
Postoperative ventral hernia
Time Frame: 2 year
Frequency of postoperative ventral hernia in the late postoperative period
2 year
Defects in the aponeurosis
Time Frame: 2 year
Frequency of aponeurosis defects in the late postoperative period
2 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alexander Inyutin, PhD MD, RyazSMU

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 12, 2018

Primary Completion (Actual)

December 12, 2021

Study Completion (Actual)

December 12, 2021

Study Registration Dates

First Submitted

August 28, 2020

First Submitted That Met QC Criteria

September 18, 2020

First Posted (Actual)

September 24, 2020

Study Record Updates

Last Update Posted (Actual)

February 14, 2022

Last Update Submitted That Met QC Criteria

February 11, 2022

Last Verified

October 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

Undecided Basic demographic data, including sex, age, and ethnicity are to be shared if allowed by the privacy policy.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gangrenous Postoperative Ventral Hernia (Diagnosis)

Clinical Trials on Suturing of a laparotomic wound with modified methods

3
Subscribe